MedTrace Logo

Evaluating Effects of Group-based CBT for Emotion Regulation in Adult ADHD

NCT07614867 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-05-29

No results posted yet for this study

Summary

Research problem and specific questions: ADHD is a highly common diagnosis, and in addition to symptoms of inattention, hyperactivity, and impulsivity, many adults with ADHD struggle with emotion regulation, impacting relationships and work life. A specific treatment for emotion regulation in ADHD, GEARS, was developed within Northern Stockholm Psychiatry and has been in use since 2014. GEARS will be evaluated through a randomized controlled trial (RCT) and a qualitative interview study.

This project aims to investigate two main questions:

1. Is GEARS an effective treatment for emotion regulation difficulties in ADHD patients?
2. How do participants perceive the impact of completing the GEARS treatment? Study 1 investigates research question 1 through an RCT comparing GEARS to a passive control group. Data are collected using validated measures before and after treatment/waiting period, as well as at six and 12 months follow ups.

Sample size: 150 participants, ensuring sufficient statistical power to detect significant between-group differences, even with some attrition.

Study 2 examines the patients' perspectives on the treatment by interviewing 15-20 participants about their experience with GEARS. The interviews focus on GEARS' perceived impact. Interviews will be recorded, transcribed, and analyzed using thematic analysis to identify key recurring themes.

Conditions

  • Attention Deficit Disorder With or Without Hyperactivity (ADHD)

Interventions

OTHER

Group Therapy for Improving Emotional Acceptance and Regulatory Skills in Adults with ADHD (GEARS)

The GEARS protocol is the first CBT based group therapy protocol describing an intervention designed specifically to treat emotion regulation in ADHD.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2029-06-30
Completion
2029-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07614867 on ClinicalTrials.gov